BIO Panel: Polymerase, Protease Inhibitor Combinations On The Horizon For Hepatitis C
This article was originally published in The Pink Sheet Daily
Executive Summary
Proof of concept study evaluating polymerase/protease inhibitor combinations for HCV could start within the next year, Vertex predicts.